The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay.
 
Maria E. Arcila
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - Raindance Technologies
 
Helena Alexandra Yu
Consulting or Advisory Role - Clovis Oncology
Research Funding - Astellas Pharma; AstraZeneca; Clovis Oncology; Incyte; Pfizer
 
Alexander E. Drilon
Honoraria - Exelixis; Genentech/Roche; Ignyta
Consulting or Advisory Role - Exelixis; Genentech/Roche
Speakers' Bureau - Ignyta
Research Funding - Foundation Medicine
Travel, Accommodations, Expenses - Exelixis; Genentech/Roche; Ignyta
 
Gregory J. Riely
Honoraria - Celgene
Consulting or Advisory Role - ARIAD; Mersana; Novartis; Roche
Research Funding - GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Novartis
 
Ahmet Zehir
No Relationships to Disclose
 
Justyna Sadowska
No Relationships to Disclose
 
David Michael Hyman
No Relationships to Disclose
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Exelixis; Genentech/Roche; Novartis; Pfizer; Threshold Pharmaceuticals
Research Funding - Pfizer (Inst); Puma Biotechnology (Inst)
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics
 
Marc Ladanyi
Stock and Other Ownership Interests - Foundation Medicine